Table 1 Patient characteristics
| Â | Patients NÂ =Â 542 |
|---|---|
Sex, n (%) | |
 Male | 81 (15) |
 Female | 461 (85) |
Migraine type, n (%) | |
 Chronic migraine | 271 (50) |
 Episodic migraine | 271 (50) |
Current dose of erenumab, n (%) | |
 70 mg | 290 (54) |
 140 mg | 252 (46) |
Insurance status, n (%) | |
 Statutory health insurance | 474 (87) |
 Private health insurance | 68 (13) |
 Treatment duration with erenumab in month, mean (SD) | 6.9 (2.7) |